AT287205B - Verfahren zur Herstellung von Arzneimittelzubereitungen - Google Patents

Verfahren zur Herstellung von Arzneimittelzubereitungen

Info

Publication number
AT287205B
AT287205B AT585969A AT585969A AT287205B AT 287205 B AT287205 B AT 287205B AT 585969 A AT585969 A AT 585969A AT 585969 A AT585969 A AT 585969A AT 287205 B AT287205 B AT 287205B
Authority
AT
Austria
Prior art keywords
production
pharmaceutical preparations
preparations
pharmaceutical
Prior art date
Application number
AT585969A
Other languages
English (en)
Inventor
Karl Gunnar Eriksson
Arnold Mangen
Original Assignee
Karl Gunnar Eriksson
Arnold Mangen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Karl Gunnar Eriksson, Arnold Mangen filed Critical Karl Gunnar Eriksson
Application granted granted Critical
Publication of AT287205B publication Critical patent/AT287205B/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
AT585969A 1968-06-19 1969-06-19 Verfahren zur Herstellung von Arzneimittelzubereitungen AT287205B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE08362/68A SE335202B (de) 1968-06-19 1968-06-19

Publications (1)

Publication Number Publication Date
AT287205B true AT287205B (de) 1971-01-11

Family

ID=20273866

Family Applications (1)

Application Number Title Priority Date Filing Date
AT585969A AT287205B (de) 1968-06-19 1969-06-19 Verfahren zur Herstellung von Arzneimittelzubereitungen

Country Status (12)

Country Link
US (1) US3670065A (de)
AT (1) AT287205B (de)
BE (1) BE734847A (de)
CA (1) CA933468A (de)
DE (1) DE1948019C3 (de)
FI (1) FI50059C (de)
FR (1) FR2011960A1 (de)
GB (1) GB1272640A (de)
HU (1) HU168386B (de)
NL (1) NL6808619A (de)
NO (1) NO129381B (de)
SE (1) SE335202B (de)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3864469A (en) * 1967-12-16 1975-02-04 Hoechst Ag Xanthines in pharmaceutical preparations and for stabilization of vitamins
US3857933A (en) * 1969-10-17 1974-12-31 Hoechst Ag Process for the manufacture of a drug dosage form permitting controlled release of active ingredient
NL7314765A (de) * 1972-10-31 1974-05-02
US3968201A (en) * 1972-11-30 1976-07-06 Pharmacia Aktiebolag Dosage unit containing a substance showing a topical effect on the eye, and a method of preparing same
SE375007B (de) * 1972-11-30 1975-04-07 Pharmacia Ab
AU520409B2 (en) * 1977-05-25 1982-01-28 Commonwealth Scientific And Industrial Research Organisation Controlled release composition
CA1146866A (en) * 1979-07-05 1983-05-24 Yamanouchi Pharmaceutical Co. Ltd. Process for the production of sustained release pharmaceutical composition of solid medical material
DE3024416C2 (de) * 1980-06-28 1982-04-15 Gödecke AG, 1000 Berlin Verfahren zur Herstellung von Arzneimitteln mit retardierter Wirkstoff-Freisetzung
US4421736A (en) * 1982-05-20 1983-12-20 Merrel Dow Pharmaceuticals Inc. Sustained release diethylpropion compositions
US4591496A (en) * 1984-01-16 1986-05-27 Massachusetts Institute Of Technology Process for making systems for the controlled release of macromolecules
US4713245A (en) * 1984-06-04 1987-12-15 Mitsui Toatsu Chemicals, Incorporated Granule containing physiologically-active substance, method for preparing same and use thereof
US5082655A (en) * 1984-07-23 1992-01-21 Zetachron, Inc. Pharmaceutical composition for drugs subject to supercooling
US4764378A (en) * 1986-02-10 1988-08-16 Zetachron, Inc. Buccal drug dosage form
DE3610878A1 (de) * 1986-04-01 1987-10-08 Boehringer Ingelheim Kg Formlinge aus pellets
US5290569A (en) * 1990-04-12 1994-03-01 Shionogi & Co., Ltd. Coated composition and its preparation process
US5153002A (en) * 1991-03-04 1992-10-06 University Of Montreal Biocompatible gradient controlled release implant
DE19705538C1 (de) * 1997-02-14 1998-08-27 Goedecke Ag Verfahren zur Trennung von Wirkstoffen in festen pharmazeutischen Zubereitungen
US6743756B2 (en) * 2001-01-26 2004-06-01 Benchmark Research And Technology, Inc. Suspensions of particles in non-aqueous solvents
MXPA04002979A (es) * 2001-09-28 2005-06-20 Johnson & Johnson Formas de dosificacion de liberacion modificada.
US20040259809A1 (en) * 2003-06-17 2004-12-23 Pediamed Pharmaceuticals, Inc. Pharmaceutical compositions including an antihistamine and a stimulant and method of use thereof
DE102004002732B4 (de) * 2004-01-20 2006-11-16 Dr. Paul Lohmann Gmbh Kg Herstellungsverfahren für mikroverkapselte Eisen-II-Sulfat enthaltende Partikel sowie Eisen-II-Sulfat enthaltende Partikel mit Mikroverkapselungen
US8673352B2 (en) 2005-04-15 2014-03-18 Mcneil-Ppc, Inc. Modified release dosage form
US20090060983A1 (en) * 2007-08-30 2009-03-05 Bunick Frank J Method And Composition For Making An Orally Disintegrating Dosage Form
WO2009058798A2 (en) * 2007-10-31 2009-05-07 Mcneil-Ppc, Inc. Orally disintegrated dosage form
US8858210B2 (en) 2009-09-24 2014-10-14 Mcneil-Ppc, Inc. Manufacture of variable density dosage forms utilizing radiofrequency energy
US9610224B2 (en) * 2009-09-24 2017-04-04 Johnson & Johnson Consumer Inc. Manufacture of tablet in a die utilizing powder blend containing water-containing material
US8313768B2 (en) 2009-09-24 2012-11-20 Mcneil-Ppc, Inc. Manufacture of tablet having immediate release region and sustained release region
US20110070286A1 (en) * 2009-09-24 2011-03-24 Andreas Hugerth Process for the manufacture of nicotine-comprising chewing gum and nicotine-comprising chewing gum manufactured according to said process
US9445971B2 (en) 2012-05-01 2016-09-20 Johnson & Johnson Consumer Inc. Method of manufacturing solid dosage form
US9511028B2 (en) 2012-05-01 2016-12-06 Johnson & Johnson Consumer Inc. Orally disintegrating tablet
US9233491B2 (en) 2012-05-01 2016-01-12 Johnson & Johnson Consumer Inc. Machine for production of solid dosage forms
BR112016015944A8 (pt) 2014-01-10 2020-06-09 Johnson & Johnson Consumer Inc processo para produzir comprimido, que usa radiofrequência e partículas revestidas dissipadoras de energia
US10493026B2 (en) 2017-03-20 2019-12-03 Johnson & Johnson Consumer Inc. Process for making tablet using radiofrequency and lossy coated particles

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3061510A (en) * 1958-08-01 1962-10-30 Olin Mathieson Radioactive iodinated (i131) fatty material admixed with wax-like material in capsule
NL269886A (de) * 1960-10-04
US3297804A (en) * 1964-05-19 1967-01-10 Ono Pharmaceutical Co Method of filling hard capsules with granules by the open-mouth-down punching method
US3308217A (en) * 1965-02-09 1967-03-07 Lowy Lawrence Method of granulating materials for subsequent forming into tablets
US3374146A (en) * 1966-04-18 1968-03-19 American Cyanamid Co Sustained release encapsulation

Also Published As

Publication number Publication date
FI50059C (fi) 1975-12-10
FR2011960A1 (de) 1970-03-13
NO129381B (de) 1974-04-08
NL6808619A (de) 1969-12-23
DE1948019A1 (de) 1971-03-25
SE335202B (de) 1971-05-17
FI50059B (de) 1975-09-01
DE1948019B2 (de) 1975-10-16
US3670065A (en) 1972-06-13
CA933468A (en) 1973-09-11
BE734847A (de) 1969-12-01
GB1272640A (en) 1972-05-03
DE1948019C3 (de) 1979-06-13
HU168386B (de) 1976-04-28

Similar Documents

Publication Publication Date Title
AT287205B (de) Verfahren zur Herstellung von Arzneimittelzubereitungen
CH543478A (de) Verfahren zur Herstellung von Glykolaminen
AT306930B (de) Verfahren zur Herstellung von 1-Glykosyl-5-azacytosinen
AT291254B (de) Verfahren zur herstellung von 3-amino-4jod-5-methyllisoxazolen
AT285811B (de) Verfahren zur Herstellung haltbarer Vitaminzubereitungen
AT296964B (de) Verfahren zur Herstellung von 1-Hydroxyphenyl-2-aminoäthanolen
AT289084B (de) Verfahren zur Herstellung von Trimethyl-p-benzochinon
AT294064B (de) Verfahren zur Herstellung von 1-Alkyl-2-aminomethylpyrrolidinen
AT295757B (de) Verfahren zur Herstellung von Benzindenen
AT282024B (de) Verfahren zur Herstellung von Pigmentzubereitungen
AT302982B (de) Verfahren zur Herstellung von Monochloralkenen
AT304461B (de) Verfahren zur herstellung von 2-aethylhexanol
AT305200B (de) Verfahren zur Herstellung von Zubereitungen von Polyadditionsprodukten
CH523230A (de) Verfahren zur Herstellung von N-Fluoracetylamino-methyl-harnstoffen
AT296254B (de) Verfahren zur Herstellung von 2-Acyloxythionobenzamiden
CH486444A (de) Verfahren zur Herstellung von 7-Cyan-cumarinen
AT318920B (de) Verfahren zur Herstellung stabiler Zubereitungen
AT289381B (de) Verfahren zur Herstellung von trans-Polypentenamer
AT314097B (de) Verfahren zur Herstellung von 19-Norsteroiden
AT286252B (de) Verfahren zur Herstellung von 3-Aminopropanolen
AT292205B (de) Verfahren zur Herstellung von 1-Peracylglykosyl-5-azacytosinen
AT301880B (de) Verfahren zur Herstellung von Copolyukondensaten
AT289737B (de) Verfahren zur Herstellung von Sulfatobetainen
CH529835A (de) Verfahren zur Herstellung von Eiweiss
CH511254A (de) Verfahren zur Herstellung von 1-Thiono-2-halogen- bzw. -3-alkylphospolinen

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee